Browsing: Longevity

For decades, longevity felt like the playground of the elite—biohackers with unlimited time, money, and curiosity turning their bodies into experiments

As cell-based medicine moves from the lab toward the clinic across diabetes, transplant, and aging, Avaí Bio and partner Austrianova have banked the genetically modified cells that will manufacture their encapsulated alpha-Klotho product

March 16, 2026 ByLynne Christensen, Staff Writer

In recent years, one of the fastest-growing areas in the biotechnology and health industry has been anti-aging and longevity science.  Aging is no longer viewed merely as an inevitable natural process, but increasingly as a biological phenomenon that can be understood, regulated, and potentially optimized

Recent studies on aging have latched onto a “player” in longevity that had hitherto received little attention: nicotinamide adenine dinucleotide, or NAD for short

Understanding China’s Longevity Market: Industry Segments, Trends and Opportunities October 21, 2025 Posted by China BriefingWritten by

{w3tc_lazyload_99588faa4e9063e48b1949faaf1b9da6_35} {w3tc_lazyload_99588faa4e9063e48b1949faaf1b9da6_36}

Much of the enthusiasm for these ‘anti-ageing’ products is based on animal studies, mostly involving rodents

Skip Navigation Jamie Justice, a scientific researcher who studies aging and the executive vice president of the health domain at XPrize Foundation. Courtesy of Jamie Justice.

A Lancome employee recently swabbed under my eyes and took a hyper-zoomed photo of my forehead, already shiny and flaking. Then she inserted my protein samples into the company’s Cell BioPrint machine, which gave its verdict in horrifying, flashy red letters: I was suffering from accelerated aging